Skip to content

Effects of animal-assisted psychotherapy incorporating mindfulness and self-compassion in neurorehabilitation: a randomized controlled feasibility trial.

Pascale Künzi, Michael Ackert, Martin Grosse Holtforth, Margret Hund-Georgiadis, Karin Hediger

Scientific Reports June 28, 2022 DOI: 10.1038/s41598-022-14584-1 (opens in new tab)

The journal has published a correction to this paper. Read the correction (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 31
Population Patients with acquired brain injury
Interventions Mindfulness- and self-compassion-based group intervention (MSCBI) animal-assisted MSCBI
Duration 6-week intervention, with post-treatment and follow-up assessments
Topics Meditation Psychedelic-assisted therapy
Keywords Animals Humans Brain injuries Feasibility studies Neurological rehabilitation Self-compassion
Key findings Both the animal-assisted and standard MSCBI groups showed significant reductions in psychological distress from pre-treatment to follow-up, with no significant difference between groups. The animal-assisted group reported significantly greater within-session increases in feeling secure, accepted, comforted, grateful, motivated, and at ease, and had significantly higher session adherence; attrition did not differ significantly. The authors suggest animal assistance may increase acceptability and commitment to psychotherapy.

Abstract

Transdiagnostic psychotherapeutic approaches are increasingly used in neurorehabilitation to address psychological distress. Animal-assistance is thought to increase efficacy. The present study evaluates a psychotherapeutic mindfulness- and self-compassion-based group intervention (MSCBI) with and without animal-assistance for patients with acquired brain injury. Patients (N = 31) were randomly assigned to the 6-week intervention with (n = 14) or without animal-assistance (n = 17). Primary outcome was psychological distress at post- and follow-up treatment, secondary outcomes were changes within-session of patients' emotional states, adherence to treatment and attrition. Psychological distress significantly decreased in both groups from pre- to follow-up treatment with no difference between groups. Patients in the animal-assisted MSCBI group reported significantly higher increases in feeling secure, accepted, comforted, grateful, motivated and at ease during the sessions compared to patients in the MSCBI group without animal-assistance. Adherence to sessions was significantly higher in the animal-assisted MSCBI group. Attrition did not significantly differ between groups. Our results show that both MSCBIs with and without animal-assistance are feasible and effective in reducing psychological distress in patients with acquired brain injury. The significant changes within-sessions mainly in relationship-based emotional states and the higher treatment adherence suggest additional effects of animal-assistance. Animal-assistance might increase acceptability and patients' commitment to psychotherapy.

Comparable studies

Other randomized controlled trials on psychedelic-assisted therapy, most cited first.

Study Year Design Participants
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Healthy adults, mostly hallucinogen-naïve 2011 Randomized controlled trial n = 18
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases Patients with anxiety associated with life-threatening diseases 2014 Randomized controlled trial n = 12
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Patients with chronic post-traumatic stress disorder refractory to both psychotherapy... 2010 Randomized controlled trial n = 20
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder Adults aged 25–65 with DSM-IV alcohol dependence and at least 4 heavy drinking days in... 2022 Randomized controlled trial n = 95
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Military veterans and first responders aged 18 or older with chronic PTSD lasting 6... 2018 Randomized, double-blind, dose-response, phase 2 clinical trial n = 26

Citations in the library

Explore topics